Neurocrine Biosciences Interview Guide

Neurocrine Biosciences is a pioneering biopharmaceutical company that specializes in neuroscience, driven by a mission to alleviate suffering for individuals facing significant health challenges. Since its inception in 1992, the company has dedicated itself to discovering and developing transformative treatments for a variety of neurological, neuroendocrine, and neuropsychiatric disorders. Neurocrine boasts a diverse portfolio of FDA-approved therapies, including those for tardive dyskinesia, chorea associated with Huntington's disease, and conditions such as classic congenital adrenal hyperplasia and endometriosis—some developed in collaboration with AbbVie. With a robust pipeline of compounds in mid- to late-phase clinical development, Neurocrine continues to leverage its deep understanding of the complex interplay between brain and body systems, reinforcing its commitment to pioneering brave science.